Clonidine gel - Curatek Pharmaceuticals
Latest Information Update: 31 Dec 2021
At a glance
- Originator Curatek Pharmaceuticals
- Class Analgesics; Anti-inflammatories; Antiglaucomas; Antimigraines; Behavioural disorder therapies; Centrally-acting antihypertensives; Chlorobenzenes; Imidazolines; Small molecules
- Mechanism of Action Alpha 2 adrenergic receptor agonists; Imidazoline I1 receptor agonists; Imidazoline receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Diabetic neuropathies; Postherpetic neuralgia
Most Recent Events
- 04 May 2007 Discontinued - Phase-III for Diabetic neuropathies in USA (Topical)
- 04 May 2007 Discontinued - Phase-III for Postherpetic neuralgia in USA (Topical)
- 13 Mar 2000 Phase-III clinical trials for Diabetic neuropathies in USA (Topical)